Identification of a molecular communications pathway that influences the mobilization of hematopoietic (blood) stem cells could lead to targeted therapies for improving bone marrow transplant success rates. In a bed-side to bench approach, researchers at Cincinnati Children's Hospital Medical Center report in Nature Medicine that pharmacological inhibition of a signaling pathway triggered by ...